Aging And Chronic Diseases Will Boost Minimally Invasive Cardiac Solutions
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 9 Analysts
Published
05 Aug 25
Updated
21 Aug 25
AnalystHighTarget's Fair Value
US$60.00
37.2% undervalued intrinsic discount21 Aug
US$37.66
1Y
48.0%7D
6.2%